Results 181 to 190 of about 789,285 (380)

Single Test‐Based Diagnosis and Subtyping of Pulmonary Hypertension Caused by Fibrosing Mediastinitis Using Plasma Metabolic Analysis

Advanced Science, EarlyView.
Pulmonary hypertension caused by fibrosing mediastinitis has a five‐year survival rate of just 56%. Current diagnostic approaches are complex for patients with mobility limitations and can lead to misdiagnoses due to their nonspecific clinical features.
Yating Zhao, Chunmeng Ding, Hongling Su, Aqian Wang, Aiping Tang, Hongfan Zhao, Ya Ma, Min Zhang, Wanshan Liu, Ruimin Wang, Ziyue Zhang, Shouzhi Yang, Dingyitai Liang, Yida Huang, Kun Qian, Lin Huang, Qihua Fu, Yunshan Cao   +17 more
wiley   +1 more source

Venous retrograde approach for endovascular angioplasty in chronic total pulmonary vein occlusion -a case report

BMC Cardiovascular Disorders
Introduction Fibrosing mediastinitis (FM) is a rare disease characterized by excessive proliferation of fibrous tissue in the mediastinum and can cause bronchial stenosis, superior vena cava obstruction, pulmonary artery and vein stenosis, etc.
Bo Li, Hai Zhu, Mengfei Jia, Jinrui Song, Tanba Carl, Gizem Koybasi, Guanming Qi, Hongling Su, Yunshan Cao   +8 more
doaj   +1 more source

Treatment of Chronic Pulmonary Heart Disease with Traditional Chinese Medicine: A Protocol for the Development of a Core Outcome Set (COS-TCM-CPHD). [PDF]

Evid Based Complement Alternat Med, 2021
Niu B, Zhang M, Chua HZ, Li K, Zhang J.
europepmc   +1 more source

Resilience in Chronic Obstructive Pulmonary Disease and Chronic Heart Failure [PDF]

, 2016

core   +1 more source

Measurement of Pulmonary Edema in Valvular Heart Disease [PDF]

, 1967
Michael McCredie
openalex   +1 more source

Pulmonary heart disease

Journal of the American College of Cardiology, 1987
Joseph C. Ross, Benjamin Burrows, Joseph S. Alpert   +2 more
openaire   +2 more sources

Biomimetic MOF Nanocarrier‐Mediated Synergistic Delivery of Mitochondria and Anti‐Inflammatory miRNA to Alleviate Acute Lung Injury

Advanced Science, EarlyView.
A biomimetic MOF nanocarrier for macrophage‐targeting delivery of both mitochondria and anti‐miR‐127 is designed with an aim to revitalize macrophages and remold the inflammatory microenvironment for treating acute lung injury. By leveraging the macrophages‐targeting property and pH‐responsiveness, ZIF‐8 nanocarriers facilitated efficient delivery of ...
Xin Shou, Changjiang Chen, Hangjie Ying, Zhiyun Liu, Lingyao Zeng, Qiujie Li, Lanjie Lei, Bingyong Mao, Wei Zhang, Shumao Cui, Liyun Shi   +10 more
wiley   +1 more source

Sendaway capillary NT-proBNP in pulmonary hypertension

BMJ Open Respiratory Research
Background N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a biomarker of cardiac ventricular wall stress that is incorporated into pulmonary hypertension (PH) risk stratification models.
Eleanor Morris, Stephen J Wort, Martin K Johnson, James L Lordan, Daniel S Knight, Chloe Roddis, Charlotte Durrington, Harrison D Stubbs, John Cannon, Emily Knightbridge, Wendy Gin-Sing, Fiona Massey, Ruta Virsinskaite, Eleanor Sear, Joy Apple-Pinguel   +14 more
doaj   +1 more source

Effects of Aminophylline on the Pulmonary Circulation and Left Ventricular Performance in Patients with Valvular Heart Disease [PDF]

, 1968
Gerald W. Murphy, Bernard F. Schreiner, Paul N. Yu   +2 more
openalex   +1 more source

Inhalable Polymeric Nanoparticle Containing Triphenylphosphanium Bromide‐modified Sonosensitizer for Enhanced Therapy of Acute Bacterial Pneumonia

Advanced Science, EarlyView.
Bacterial pneumonia is the sixth leading cause of death. In this study, an inhalable polymeric nanoparticle NPFCPS‐P is developed, which under US stimulation showed high efficacy in the treatment of acute bacterial pneumonia. This nanoplatform would be much less prone to select bacterial resistance and represented a promising measure for antibiotics ...
Lin Wang, Fangzhou Chen, Nier Wu, Lingfei Hu, Haihua Xiao, Hanchen Zhang, Dongsheng Zhou   +6 more
wiley   +1 more source